636011000001100: PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug)\PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Aspirin\Product containing only aspirin in oral dose form (medicinal product form)\Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug)\PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Aspirin\Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug)\PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)
\UK product\Trade family\PostMI\PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing platelet aggregation inhibitor (product)\Product containing aspirin\Aspirin\Product containing only aspirin in oral dose form (medicinal product form)\Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug)\PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing platelet aggregation inhibitor (product)\Product containing aspirin\Aspirin\Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug)\PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing platelet aggregation inhibitor (product)\Product containing aspirin\Product containing aspirin in oral dose form (medicinal product form)\Product containing only aspirin in oral dose form (medicinal product form)\Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug)\PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing salicylate\Product containing aspirin\Aspirin\Product containing only aspirin in oral dose form (medicinal product form)\Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug)\PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing salicylate\Product containing aspirin\Aspirin\Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug)\PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing salicylate\Product containing aspirin\Product containing aspirin in oral dose form (medicinal product form)\Product containing only aspirin in oral dose form (medicinal product form)\Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug)\PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing aspirin in oral dose form (medicinal product form)\Product containing only aspirin in oral dose form (medicinal product form)\Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug)\PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

16414101000001118 PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

16414201000001113 PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Is a	Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug)	true	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) freeness indicator	Sugar free	false	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Has dispensed dose form	Dispersible tablet	true	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Has active ingredient	Aspirin	true	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Is a	PostMI	true	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Has specific active ingredient	Aspirin	true	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Has dispensed dose form	Dispersible tablet	false	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Has dispensed dose form	Dispersible tablet	false	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Has dispensed dose form	Dispersible tablet	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd) 28 tablet	Is pack of	False	PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier
PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd) 28 tablet	Has AMP	True	PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
16414101000001118	PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
16414201000001113	PostMI 75 dispersible tablets (Ashbourne Pharmaceuticals Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module